Stay updated on NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial
Sign up to get notified when there's something new on the NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial page.

Latest updates to the NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial page
- Check5 days agoChange DetectedRevision v3.5.2 was added and revision v3.5.0 was removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe Record History shows the addition of revision v3.5.0 and the removal of revision v3.4.3.SummaryDifference0.1%

- Check42 days agoChange DetectedA new revision entry (v3.4.3) was added to the history log, replacing the previous revision (v3.4.2). This reflects a metadata update to the page without changes to core study data.SummaryDifference0.1%

- Check70 days agoChange DetectedRecord history shows a new Revision: v3.4.2 was added and the prior funding-notice revision (v3.4.1) was removed. This reflects maintenance/versioning rather than substantive study content.SummaryDifference0.7%

- Check77 days agoChange DetectedAdded a banner notice about government funding and operating status, and updated the release version to v3.4.1, replacing v3.4.0.SummaryDifference0.7%

- Check84 days agoChange DetectedMinor UI updates on the history page, including a Show glossary option and color-coded indicators for additions and deletions, along with an updated version note (Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

Stay in the know with updates to NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial page.